ArticleJMA journal2026
Postoperative D-dimer-based Screening for Venous Thromboembolism after Total Hip Arthroplasty: A Retrospective Cohort Study of 1,651 Hips.
Article in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a serious complication after total hip arthroplasty (THA). Although D-dimer testing is widely used for VTE screening, there is no consensus regarding its optimal cutoff value or screening strategy after THA. The purpose of this study was to evaluate the validity of a postoperative VTE screening strategy based on a D-dimer cutoff value of 10.0 μg/mL measured at 1 week after unilateral THA. Methods: This retrospective observational study included 1,651 unilateral THAs at a single institution between April 2007 and March 2023. Serum D-dimer levels were routinely measured at 1 week postoperatively. Patients with D-dimer levels ≥10.0 μg/mL underwent contrast-enhanced computed tomography (CT) to evaluate for DVT and/or PE. Demographic, clinical, and perioperative variables were analyzed, and multivariable regression analyses were performed to identify factors associated with postoperative D-dimer levels and VTE. Results: Postoperative D-dimer levels ≥10.0 μg/mL were observed in 343 hips (20.8%), among which 31 hips were diagnosed with VTE. Of these, 22 hips had isolated DVT, seven had isolated PE, and two had both DVT and PE. Appropriate anticoagulation therapy was initiated in all diagnosed cases, and no fatal or clinically severe VTE events occurred. Patients with VTE had significantly higher D-dimer levels compared to those without VTE. Multivariable analysis demonstrated that female sex, advanced age, diabetes treated with medication, and greater intraoperative blood loss were independently associated with higher postoperative D-dimer levels. Conclusions: A postoperative D-dimer-based screening strategy incorporating contrast-enhanced CT for patients with D-dimer levels ≥10.0 μg/mL at 1 week after THA appeared to be feasible and clinically acceptable, with no severe thromboembolic events observed in this cohort of 1,651 hips. However, further studies are warranted to determine the optimal cutoff value for postoperative D-dimer screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.